1α,25-dihydroxy vitamin D3 induces nuclear matrix association of the 1α,25-dihydroxy vitamin D3 receptor in osteoblasts independently of its ability to bind DNA

Journal of Cellular Physiology

Volumn 222, Issue 2, 2010, Pages 336-346

  Arriagada, Gloria ^a   Paredes, Roberto ^a,c   Van Wijnen, Andre J ^b   Lian, Jane B ^b   Van Zundert, Brigitte ^a   Stein, Gary S ^b   Stein, Janet L ^b   Montecino, Martin ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; PROTEIN DRIP205; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; DNA; HYBRID PROTEIN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL NUCLEUS MATRIX; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; TRANSCRIPTION REGULATION; ANIMAL; BINDING SITE; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOUSE; MUTATION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

EUKARYOTA;

ANIMALS; BINDING SITES; CALCITRIOL; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA; HUMANS; LIGANDS; MEDIATOR COMPLEX SUBUNIT 1; MICE; MUTATION; NUCLEAR MATRIX; OSTEOBLASTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, CALCITRIOL; RECOMBINANT FUSION PROTEINS; TRANSCRIPTIONAL ACTIVATION; TRANSDUCTION, GENETIC;

EID: 73349130791     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21958     Document Type: Article

References (66)

1. Arbour NC, Prahl JM, DeLuca HF. 1993. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. Mol Endocrinol 7:1307-1312.
2. Bae JS, Gutierrez S, Narla R, Pratap J, Devados R, van Wijnen A, Stein JL, Stein GS, Lian JB, Javed A. 2007. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP-2 signaling through a Runx2 functional domain during osteoblast differentiation. J Cell Biochem 100:434-449.
3. Banerjee C, MaCabe L, Choi J, Hiebert S, Stein J, Stein G, Lian J. 1997. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66:1-8.
4. Barry J, Leong G, Church B, Issa L, Eisman J, Gardiner E. 2003. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix 10 residues. J Biol Chem 278:8224-8228.
5. Barsony J, Renyi I, McKoy W. 1997. Subcellular distribution of normal and mutant vitamin D receptor in living cells. J Biol Chem 272:5774-5782.
6. Baumann CY, Ma H, Wolford R, Reyes JC, Maruvada P, Lim C, Yen PM, Stallcup MR, Hager GL. 2001. The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol 15:485-500.
7. Bidwell JP, van Wijnen AJ, Fey EG, Dworetzky S, Penman S, Stein J, Lian JB, Stein GS. 1993. Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci USA 90:3162-3166.
8. Black BE, Paschal BM. 2004. Intranuclear organization and function of the androgen receptor. Trends Endocrinol Metab 15:411-417.
9. Black BE, Holaska JM, Rastinejad F, Paschal BM. 2001. DNAbinding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol 11:1749-1758.
10. Carvallo L, Henriquez B, Paredes R, Olate J, Onate S, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M. 2008. 1a,25-dihydroxyvitamin D3-enhanced transcription of the bone-specific osteocalcin gene involves preferential recruitment of the coactivator SRC-1. J Cell Physiol 214:740-749.
11. Choi J-Y, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS. 2001. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA 98:8650-8655.
12. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. 2003. New insights into the mechanisms of vitamin D action. J Cell Biochem 88:695-705.
13. Cook PR. 1999. The organization of replication and transcription. Science 284:1790-1795.
14. Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA. 1999. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 145:1119-1131.
15. Csaky KG. 2001. Preparation of recombinant adenoviruses. In: Rokoczy PE, editor. Vision Research protocol. New York: Human Press. pp. 141-155.
16. Day RN, Nordeen SK, Wan Y. 1999. Visualizing protein-protein interactions in the nucleus of the living cells. Mol Endocrinol 13:517-526.
17. Deng C, Ueda E, Chen KE, Bula C, Norman AW, Luben RA, Walker AM. 2009. Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Mol Endocrinol 23:226-236.
18. Ducy P, Zhang R, Geofrroy V, Ridall AL, Karsenty G. 1997. Osf/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
19. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RMA. 1994. Novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
20. Haussler MR, Jurutka PW, Hsieh J-C, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. 1995. Newunderstanding of the molecular mechanism of the vitamin Dreceptor-mediated genomic actions of the vitamin D hormone. Bone 17:33S-38S.
21. Hsieh J-C, Jurutka PW, Nakajima S, Galligan MA, Haussler CA, Shimizu N, Whitfield GK, Haussler MR. 1993. Phosphorylation of the human vitamin Dreceptor by protein kinase C: Biochemical and functional evaluation of the serine 51 recognition site. J Biol Chem 268:15118-15126.
22. Huber LJ, Chodosh LA. 2005. Dynamics of DNA repair suggested by the subcellular localization of BRCA1 and BRCA2 proteins. J Cell Biochem 96:47-55.
23. Iborra FJ, Jackson DA, Cook PR. 2000. The path of RNA through nuclear pores: Apparent entry from the sides into specialized pores. J Cell Sci 113:291-302.
24. Javed A, Guo B, Hiebert S, Choi J-Y, Green J, Zhao S-C, Osborne MA, Stifani S, Stein JL, Lian JB. 2000. Groucho/TLE/Resp proteins associate with the nuclear matrix and repress RUNX (CBFa/AML/PEBP2a) dependent activation of tissue-specific gene transcription. J Cell Sci 113:2221-2231.
25. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2008. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283:8412-8422.
26. Kim S, Shevde NK, Pike JW. 2005. 1,25-dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 20:305-317.
27. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A, Nakagawa T, Ito T, Ishimi Y, Nagasawa H, Matsumoto T, Yanagisawa J, Kato S. 2003. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113:905-917.
28. Kornberg RD. 2005. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci 30:235-239.
29. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS. 2004. Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14:1-41.
30. Ma H, Siegel AJ, Berezney R. 1999. Association of chromosome territories with the nuclear matrix: Disruption of human chromosome territories correlates with the release of a subset of nuclear matrix proteins. J Cell Biol 146:531-542.
31. MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler M. 1993. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13:5907-5917.
32. Mahonen A, Maenpaa PH. 1994. Steroid hormone modulation of vitamin Dreceptor levels in human MG-63 osteosarcoma cells. Biochem Biophys Res Commun 205:1179-1186.
33. Majeska RJ, Rodan SB, Rodan GA. 1980. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107:1494.
34. Merriman H, van Wijnen A, Hiebert S, Bidwell J, Fey E, Lian J, Stein J, Stein G. 1995. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: Interactions with the osteocalcin gene promoter. Biochemistry 34:13125-13132.
35. Misteli T, Spector DL. 1999. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. Mol Cell 3:697-705.
36. Montecino M, Stein G, Cruzat F, Marcellini S, Stein J, Lian J, van Wijnen A, Arriagada G. 2007. An architectural perspective of vitamin D responsiveness. Arch Biochem Biophys 41:272-278.
37. Nangia AK, Butcher JC, Konety BR, Vietmeier BM, Getzenberg RM. 1998. Association of vitamin D receptors with the nuclear matrix of human and rat genitourinary tissues. J Steroid Biochem Mol Biol 66:241-246.
38. Norman AW, Mizwicki MT, Norman DP. 2004. Steroid-hormone rapid actions, membrane receptors and conformational ensemble model. Nat Rev Drug Discov 3:27-41.
39. Olson MO, Hingorani K, Szebeni A. 2002. Conventional and nonconventional roles of the nucleolus. Int Rev Cytol 219:199-266.
40. Owen TO, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. 1990. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
41. Parada LA, McQueen PG, Misteli T. 2004. Tissue-specific spatial organization of genomes. Genome Biol 5:R44.
42. Paredes R, Gutierrez J, Gutierrez S, Allison L, Puchi M, Imschenetzky M, van Wijnen AJ, Lian J, Stein GS, Stein JL, Montecino M. 2002. Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodeling. Biochem J 363:667-676.
43. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi SK, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M. 2004. The bone-specific transcription factor RUNX2 interacts with the 1a,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24:8847-8861.
44. Prufer K, Barsony J. 2002. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Enocrinol 16:1738-1751.
45. Rachez C, Freedman LP. 2000. Mechanisms of gene regulation by vitamin D(3) receptor: A network of coactivator interactions. Gene 246:9-21.
46. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar A, Erdjument-Bromage H, Tempst P, Freedman L. 1999. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-828.
47. Ross TK, Moss VE, Prahl JM, DeLuca H. 1992. A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its responsive elements. Proc Natl Acad Sci USA 89:256-260.
48. Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, Cai X, Wang Z. 2003. Identification and characterization of the ligand-regulated nuclear export signal in androgen receptor. J Biol Chem 278:41998-42005.
49. Scully R, Livingston DM. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429-432.
50. Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M. 2003. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 23:3339-3351.
51. Smith KP, Moen PT, Wydner KL, Coleman JR, Lawrence JB. 1999. Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific. J Cell Biol 144:617-629.
52. Staal A, van Wijnen A, Birkenhager J, Pols H, Prahl J, DeLuca H, Gaub M, Lim J, Stein G, van Leeuwen J, Stein J. 1996. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol 10:1444-1456.
53. Stein GS, Lian JB, Montecino M, van Wijnen AJ, Stein JL, Javed A, Zaidi SK. 2002. Involvement of nuclear architecture in regulating gene expression in bone cells. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press. pp 169-188.
54. Stenoien D, Mancini M, Patel K, Allegreto E, Smith C, Mancini M. 2000. Subnuclear trafficking of estrogen receptor-a and steroid receptor co-activator-1. Mol Endocrinol 14:518-534.
55. Umesono K, Murakami KK, Thompson CC, Evans RM. 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255-1266.
56. Vaisanen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. 2005. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-dihydroxyvitamin D3. J Mol Biol 350:65-77.
57. Van Driel DM, Pols HA, van Leeuwen JP. 2004. Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des 10:2535-2555.
58. Van Wijnen AJ, Bidwell JP, Fey EG, Penman S, Lian JB, Stein JL, Stein GS. 1993. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBO, OCT-1, and AP-1. Biochemistry 32:8397-8402.
59. Verschure PJ, van der Kraan I, Manders EM, van Driel R. 1999. Spatial relationship between transcription sites and chromosome territories. J Cell Biol 147:13-24.
60. Wagner S, Chiosea S, Nickerson JA. 2003. The spatial targeting and nuclear matrix binding domains of SRm160. Proc Natl Acad Sci USA 100:3269-3274.
61. Zaidi SK, Javed A, Choi JY, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2001. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci 114:3093-3102.
62. Zaidi SK, Young DW, Choi JY, Pratap J, Javed A, Montecino M, Stein JL, van Wijnen AJ, Lian JB, Stein GS. 2005. The dynamic organization of gene-regulatory machinery in nuclear microenvironments. EMBO Rep 6:128-133.
63. Zella LA, Kim S, Shevde NK, Pike JW. 2006. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol Endocrinol 20:1231-1247.
64. Zeng C, McNeil S, Pockwinse S, Nickerson JA, Shopland L, Lawrence JB, Penman S, Hiebert SW, Lian JB, van Wijnen AJ, Stein JL, Stein GS. 1998. Intranuclear targeting of AML/CBFa regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci USA 95:1585-1589.
65. Zhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W, MacDonald PN. 2001. Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription. J Biol Chem 276:40614-40620.
66. Zhang C, Dowd DR, Staal A, Gu C, Lian JB, van Wijnen AJ, Stein GS, MacDonald PN. 2003. Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J Biol Chem 278:35325-35336.